Journal of Antimicrobial Chemotherapy

Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus
pp. 1-6(6)
Authors: Slater-Radosti, Courtney; Van Aller, Glenn; Greenwood, Rebecca; Nicholas, Richard; Keller, Paul M.; DeWolf, Walter E.; Fan, Frank; Payne, David J.

Antimicrobial effects of positively charged surfaces on adhering Gram-positive and Gram-negative bacteria
pp. 7-13(7)
Authors: Gottenbos, Bart; Grijpma, Dirk W.; van der Mei, Henny C.; Feijen, Jan

The effect of pharmacokinetics on the bactericidal activity of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae and the emergence of resistance
pp. 15-22(8)
Author: Thorburn, Christine E.

Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria
pp. 23-28(6)
Authors: Fuchs, Peter C.; Barry, Arthur L.

Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae
pp. 29-36(8)
Authors: Roychoudhury, Siddhartha; Twinem, Tracy L.; Makin, Kelly M.; McIntosh, Eric J.; Ledoussal, Benoit

Activity of levofloxacin and ciprofloxacin against urinary pathogens
pp. 37-45(9)
Authors: Drago, L.; De Vecchi, E.; Mombelli, B.; Nicola, L.; Valli, M.

Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison
pp. 47-52(6)
Author: Gemmell, Curtis G.

Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems
pp. 53-62(10)
Authors: Hällgren, Anita; Abednazari, Hossein; Ekdahl, Christer; Hanberger, Håkan; Nilsson, Maud; Samuelsson, Annika; Svensson, Erik; Nilsson, Lennart E.

Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy
pp. 63-66(4)
Authors: Honeybourne, D.; Banerjee, D.; Andrews, J.

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin
pp. 67-74(8)
Authors: File, T. M.; Schlemmer, B.; Garau, J.; Cupo, M.; Young, C.

Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14-demethylase gene, pdmA
pp. 75-81(7)
Authors: Osherov, Nir; Kontoyiannis, Dimitrios P.; Romans, Angela

In vitro comparison of the antimycotic activity of a miconazole–HP--cyclodextrin solution with a miconazole surfactant solution
pp. 83-87(5)
Authors: Piel, Géraldine; Hayette, Marie Pierre; Pavoni, Ermanno; Evrard, Brigitte; Van Hees, Thierry; de Hassonville, Sandrine Henri; De Mol, Patrick

Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats
pp. 89-95(7)
Authors: Ruijgrok, Elisabeth J.; Vulto, Arnold G.

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients
pp. 97-103(7)
Authors: Boogaerts, Marc; Maertens, Johan; van Hoof, Achiel; de Bock, Robrecht; Fillet, Georges; Peetermans, Marc; Selleslag, Dominik; Vandercam, Bernard; Vandewoude, Koenraad; Zachée, Pierre

In vitro effects of photodynamic therapy on Aspergillus fumigatus
pp. 105-107(3)
Authors: Friedberg, Joseph S.; Skema, Cynthia; Baum, Eric D.; Burdick, Jeffrey; Vinogradov, Sergei A.; Wilson, David F.; Horan, Annamarie D.

The effect of amiloride on amphotericin B-induced hypokalaemia
pp. 109-111(3)
Author: Bearden, David T.

Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors
pp. 113-116(4)
Authors: Torti, Carlo; Pozniak, Anton; Nelson, Mark; Hertogs, Kurt

Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads
pp. 117-119(3)
Authors: Wichelhaus, T. A.; Dingeldein, E.; Rauschmann, M.; Kluge, S.; Dieterich, R.; Schäfer, V.

Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility tests
pp. 121-125(5)
Authors: Barry, Arthur L.; Fuchs, Peter C.

Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents
pp. 127-130(4)
Author: Horn, Ruth

In vitro and in vivo efficacy of a novel fluoro-ketolide HMR 3562 against enterococci
pp. 131-135(5)
Authors: Guitton, Michele; Delachaume, Carole; Le Priol, Pascal; Steier, Valérie

The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice
pp. 137-140(4)
Authors: Yoshizumi, Satoshi; Takahashi, Yoshie; Murata, Mitsuo; Domon, Haruki; Furuya, Nobuhiko; Ishii, Yoshikazu; Matsumoto, Tetsuya; Ohno, Akira; Tateda, Kazuhiro; Miyazaki, Shuichi

Dormancy and persistence in chronic infection: role of the general stress response in resistance to chemotherapy
pp. 141-142(2)
Author: Brown, Michael R. W.

Emergence of TetM-mediated tetracycline resistance in rural South Africa
pp. 142-143(2)
Authors: Moodley, Prashini; Hoppenbrouwers, Jules; Bohlken, Louise

Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)
pp. 143-144(2)
Authors: Johnson, Alan P.; Aucken, Hazel M.; Cavendish, Susan; Ganner, Mark; Wale, Martin C. J.; Warner, Marina; Livermore, David M.; Cookson, Barry D.

Extremely low prevalence of UK Staphylococcus aureus isolates with reduced susceptibility to vancomycin
pp. 144-145(2)
Author: Wilcox, Mark H.

Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999–2000 in Spain
pp. 145-148(4)
Authors: Alós, J. I.; Oteo, J.; Aracil, B.

In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae
pp. 148-152(5)
Authors: Schmitz, F.-J.; Boos, M.; Mayer, S.; Verhoef, J.; Milatovic, D.

Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993–1999
pp. 152-154(3)
Authors: Betriu, Carmen; Sánchez, Ana; Palau, M. Luisa; Gómez, María

Difficulties in the assay of cefamandole highlight the importance of specific methodologies in pharmacokinetic studies
pp. 154-155(2)
Author: Zhang, J.

Faecal concentrations of piperacillin and tazobactam in elderly patients
pp. 155-156(2)
Authors: Wilcox, Mark H.; Brown, Alex

Drug Interactions in Infectious Diseases
pp. 157-158(2)
Author: Dhillon, S.

Drug Interactions in Infectious Diseases
pp. 157-158(2)

Viral Hepatitis
pp. 158-159(2)

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
pp. 161-161(1)
Authors: Wootton, M.; Howe, R. A.; Hillman, R.; Walsh, T. R.; Bennett, P. M.